About

Affect Therapeutics provides a digital platform for addiction recovery, utilizing a science-based method known as contingency management. This approach combines financial incentives, therapy, and medication to encourage healthy behaviors and support individuals in overcoming their addictions. Clients can access treatment through secure video conferences, allowing for privacy and convenience without the need to visit a physical clinic. In addition to addiction treatment, Affect Therapeutics offers support in areas that affect recovery, such as job searching and financial management, recognizing that sobriety is linked to overall life improvement. The company operates on a subscription or fee-for-service model, making it distinct from traditional rehab centers by offering a fully digital and holistic approach to recovery.

Simplify's Take

What believers are saying

• Raised $16M in Series A funding for national and program expansion.
• Holds outpatient treatment licenses in 20 states, aiming for majority U.S. coverage by 2023.
• Growing telehealth adoption increases potential user base for Affect's digital platform.

What critics are saying

• Increased competition from similar digital health startups may dilute market share.
• Rapid expansion plans could strain resources and affect service quality.
• Potential data privacy concerns could lead to legal challenges.

What makes Affect Therapeutics unique

• Affect Therapeutics uses a unique contingency management approach for addiction treatment.
• The company offers a fully digital, private, and accessible platform for recovery.
• Affect Therapeutics provides holistic support, including job hunting and financial management assistance.

Help us improve and share your feedback! Did you find this helpful?

YesNo